Erschienen in:
01.02.2014 | Research Article
Gelatinase B (−1562C/T) polymorphism in tumor progression and invasion of breast cancer
verfasst von:
P. Chiranjeevi, K. Mrudula Spurthi, N. Santhoshi Rani, G. Rajesh Kumar, T. Mohini Aiyengar, M. Saraswati, G. Srilatha, G. Kishore Kumar, Sudha Sinha, C. Sanjeeva Kumari, B. Nagarjuna Reddy, S. Vishnupriya, H. Surekha Rani
Erschienen in:
Tumor Biology
|
Ausgabe 2/2014
Einloggen, um Zugang zu erhalten
Abstract
Matrix metalloproteinases (MMPs) play an important role in breast cancer tumor invasion and progression. MMP-9 is a member of the MMP family and is also known as Gelatinase B or type IV collagenases (92 kDa) and possesses proteolytic activity against type IV collagen, a major component of the basement membrane. Our study aims to examine the association of Gelatinase B (−1562C > T) promoter polymorphism with breast cancer invasion and progression. The study involves 200 breast cancer patients and age-matched 191 healthy controls. The SNP-1562C > T (rs3918242) in MMP-9 promoter region was examined by allele-specific polymerase chain reaction and gel electrophoresis. The genotypes were determined and compared between patients and controls, and the influence of the polymorphism on clinicopathological data was analyzed. The T allele of the -1562C > T MMP-9 polymorphism was detected more frequently in breast cancer patients than controls (p < 0.001). Our results suggest the clinical importance of MMP-9 gene polymorphism (−1562C > T) in breast cancer patients. The study may also help in identifying individuals at risk of developing breast cancer.